ŞANLIOĞLU, A. D. Et Al. 2008. Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death. 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy , (Brugge, Belgium), 1104.

ŞANLIOĞLU, A. D., Dirice, E., ELPEK, G. Ö., Korcum, A. F., Ozdogan, M., SÜLEYMANLAR, İ., ... BALCI, M. K.(2008). Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death . 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (pp.1104). Brugge, Belgium

ŞANLIOĞLU, AHTER Et Al. "Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death," 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belgium, 2008

ŞANLIOĞLU, AHTER D. Et Al. "Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death." 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy , Brugge, Belgium, pp.1104, 2008

ŞANLIOĞLU, A. D. Et Al. (2008) . "Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death." 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy , Brugge, Belgium, p.1104.

@conferencepaper{conferencepaper, author={AHTER DİLŞAD ŞANLIOĞLU Et Al. }, title={Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death}, congress name={16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy}, city={Brugge}, country={Belgium}, year={2008}, pages={1104} }